Table 1.
Year | Age (gender) | Substances | Route of exposure | Adverse clinical effects | Treatments | Survival | Time to ECMO from ED arrival | Duration of ECMO | ECMO-related complications | Did ECMO contribute to death? |
---|---|---|---|---|---|---|---|---|---|---|
1998 | 1 year (male) | Hydrocarbon furniture polish | Oral |
Acidosisa Aspiration Pneumothorax |
Intubation VV ECMO |
Yes | 3 days | 21 days | None reported | Not applicable |
2001 | 1 month (male) | Digoxin | IV |
Ventricular-tachycardia (Vtach)/ventricular-fibrillation (Vfib) Asystole |
Digoxin antibodies Cardioversion Cardiopulmonary resuscitation (CPR) VA ECMO |
No | < 1 day | < 1 day | None reported | No |
2001 | 9 years (male) | Imipramine | Oral |
Hypotensionb Ventricular-fibrillation |
Transvenous pacer Vasopressors VA ECMO |
Yes | 2 days | 8 days | None reported | Not applicable |
2008 | 1 year (male) | Lamp Oil | Oral |
Hypotensionb Hypoxia Respiratory arrest Aspiration |
Intubation Vasopressor VV ECMO |
Yes | < 1 day | 6 days | None reported | Not applicable |
2009 | 2 years (male) |
Digoxin Flecainide |
Oral |
Hypotensionb Bradycardiac Vtach/Vfib Seizures Asystole |
Digoxin antibodies Vasopressors Intubation VA ECMO |
Yes | < 1 day | 3 days | None reported | Not applicable |
2010 | 17 years (male) |
Atenolol Amlodipine Colchicine |
Oral |
Hypotensionb Pulmonary edema Renal failured Asystole |
Calcium Glucagon Vasopressors VA ECMO |
No | 2 days | < 1 day | None reported | No |
2011 | 45 years (male) |
Arsenic trioxide White phosphorous |
Dermal Inhalation |
Hypotensionb Vtach Cyanosis |
Vasopressors Hemodialysis Intubation VA ECMO |
Yes | 2 days | 11 days | None reported | Not applicable |
2012 | 22 years (male) | Methylenedioxymethamphetamine | Oral |
Hyperthermiae Acidosisa Ast and/or Alt > 1000 Renal failured Rhabdomyolysisf Multiple seizures Coma |
Vasopressors Hemodialysis Intubation VA ECMO |
Yes | 1 day | 2 days | Compartment syndrome at cannulation site requiring fasciotomy of right leg resulting in infection | Not applicable |
2012 | 54 years (female) | Diltiazem | Oral |
Hypotensionb Bradycardiac |
Calcium Glucagon Vasopressors High-dose insulin Intralipid Intubation VA ECMO |
Yes | < 1 day | 2 days | None reported | Not applicable |
2013 | 7 months (male) | Flecainide | Oral |
Vtach/Vfib Asystole |
Vasopressors Intralipid Intubation CPR VA ECMO |
Yes | < 1 day | 2 days | None reported | Not applicable |
2013 | 26 years (male) | Diltiazem | Oral |
Hypotensionb Bradycardiac Coma Asystole |
Glucagon Vasopressors High-dose insulin Intralipid Transvenous pacing Intubation VA ECMO |
Yes | < 1 day | 2 days | None reported | Not applicable |
2014 | 17 years (male) | Amlodipine | Oral |
Hypotensionb Respiratory arrest Asystole |
Vasopressors Intubation VA ECMO |
Yes | 1 day | unknown | None reported | Not applicable |
2014 | 1 year (female) | Hydrocarbon furniture polish | Oral |
Hypotensionb Aspiration Asystole |
Vasopressors Intubation CPR VV ECMO |
No | < 1 day | < 1 day | 5 min asystolic arrest during cannulation | Unknown |
2015 | 27 years (male) |
Cocaine Ethanol |
Oral Insufflation |
Hypotensionb Respiratory arrest Coma |
Vasopressors Intubation VA ECMO |
Yes | < 1 day | 6 days | None reported | Not applicable |
2016 | 17 years (female) |
Diltiazem Metoprolol |
IV |
Hypotensionb Asystole |
Glucagon Calcium Vasopressors Intubation CPR VA ECMO |
Yes | < 1 day | 1 day | None reported | Not applicable |
2016 | 24 years (male) | Fentanyl | Oral |
Acidosisa Respiratory arrest |
Intubation VV ECMO |
Yes | < 1 day | 3 days | None reported | Not applicable |
aAcidosis defined as serum bicarbonate < 20 mEq/L (mmol/L), pH < 7.35, or elevated lactic acid levels
bHypotension defined in adults as blood pressure < 90 mmHg systolic or more than 15 mmHg less than patient’s usual systolic blood pressure. In children, systolic blood pressure < (70 + 2(age)) mmHg
cBradycardia defined as heart rate < 60 beats per minute in adults. Age-related standards applied to children
dRenal failure defined as impairment that has produced clinically significant azotemia and loss of renal function
eHyperthermia defined as temperature ≥ 38 °C
fRhabdomyolysis defined as presence of myoglobin in the urine or a creatinine kinase (CK) level > 500 IU/L